MYP_147720
Basic Information
Desmopressin
Anti-diuretic Hemostatic
not Standard
9 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XYFQNCPRG
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0166718 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
Oxytocin/Vasopressin
9606;32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
Deamino
Amidation
Non-standard residues/X at 1
Bio-Activity Profile
Anti-diuretic Hemostatic
Human vasopressin V2 receptor
Clinical/Human: Following an intranasal dose of 1.66 mcg of desmopressin, the median apparent terminal half-life was 2.8 h. Terminal half-life significantly increased from 3 h in normal healthy patients to 9 h in patients with severe renal impairment. The oral terminal half life of desmopressin ranges from 2 to 3.11 h.